---
title: "278 Seed Medtech Investors (Nov 2026)"
last_updated: "2026-11-09"
rows: "278"
free_rows: "25"
source: "SEC Form D filings and our own research"
canonical: "https://theinvestordatabase.com/lists/seed-medtech-investors/"
---

# 278 seed medtech investors

We list 278 seed medtech investors as of November 2026: 207 have an SEC filing on file and 71 were checked on the firm's own website or an official register, and the list was last checked on 9 Nov 2026. The states with the most are California (61), New York (28) and Texas (17).

- 278 investors
- 132 with a fund filing or dated deal in the last 12 months
- $50M median fund size on file (SEC Form D, 148 firms)
- 1,351 named decision-makers on file

## First 25 of 278 seed medtech investors

| Investor | Type | HQ | Stages (our research) | Focus (our research) | Latest fund or deal | Fund size | Checked | Profile |
|---|---|---|---|---|---|---|---|---|
| 7wire Ventures | VC firm | Chicago, IL | Seed | Medtech, Healthtech, AI, SaaS | New fund, Oct 2026 | $300M (SEC Form D, 2022) | 2026-11-04 | https://theinvestordatabase.com/investors/7wire-ventures/ |
| HealthX Ventures | VC firm | Madison, WI | Seed | Medtech, Healthtech, AI, SaaS | New deal, Sep 2026 | $100M (SEC Form D, 2023) | 2026-11-05 | https://theinvestordatabase.com/investors/healthx-ventures/ |
| Mercia Asset Management | Fund manager | Henley-in-Arden, United Kingdom | Seed, Series A, Growth | Medtech, Healthtech, Future of Work, AI | Portfolio news, Oct 2026 | £400M (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/mercia/ |
| SHD Partners | VC firm | Dallas, TX | Seed, Series A | Medtech, Healthtech, Biotech | Portfolio news, Nov 2026 | $61M (SEC Form ADV) | 2026-11-05 | https://theinvestordatabase.com/investors/shd-partners/ |
| Digitalis Ventures | VC firm | New York, NY | Seed | Medtech, Healthtech, Biotech | Portfolio news, Nov 2026 | $862M (SEC Form ADV) | 2026-11-05 | https://theinvestordatabase.com/investors/digitalis-ventures/ |
| HC9 Ventures | VC firm | Havertown, PA | Seed, Series A | Medtech, Healthtech, AI, Fintech | New fund, Oct 2026 | $85M (SEC Form D, 2025) | 2026-11-04 | https://theinvestordatabase.com/investors/hc9-ventures/ |
| Fountain Healthcare Partners | VC firm | Dublin, Ireland | Seed | Medtech, Healthtech, Biotech | Portfolio news, Oct 2026 | €425M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/fountain-healthcare-partners/ |
| Gore Range Capital | VC firm | Southlake, TX | Seed | Medtech, Healthtech, Biotech | New deal, Aug 2026 | $250M (SEC Form D, 2026) | 2026-11-04 | https://theinvestordatabase.com/investors/gore-range-capital/ |
| BGF | VC firm | United Kingdom | Seed, Series A, Series B, Growth | Medtech, Healthtech, Edtech, Developer Tools | Portfolio news, Oct 2026 | £3.0B (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/bgf/ |
| 25Madison Ventures | VC firm | New York, NY | Pre-seed, Seed, Series A | Medtech, Healthtech, AI, Logistics | New fund, Oct 2026 | $50M (SEC Form D, 2026) | 2026-11-04 | https://theinvestordatabase.com/investors/25madison-ventures/ |
| Cambridge Angels | Angel network | Cambridge, United Kingdom | Seed | Medtech, Healthtech, Biotech, Deep Tech | Portfolio news, Oct 2026 | £400M (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/cambridge-angels/ |
| Heinz Ventures, LLC | VC firm | Memphis, TN | Pre-seed, Seed | Medtech, Healthtech | New deal, Aug 2026 | $10M (SEC Form D, 2024) | 2026-11-04 | https://theinvestordatabase.com/investors/heinz-ventures-llc/ |
| Hatteras Venture Partners | VC firm | Durham, NC | Seed | Medtech, Healthtech, Biotech | New fund, Oct 2026 | $250M (SEC Form D, 2023) | 2026-11-04 | https://theinvestordatabase.com/investors/hatteras-venture-partners/ |
| Safar Partners | VC firm | Cambridge, MA | Seed | Medtech, Healthtech, Industrial Tech, Biotech | New deal, Aug 2026 | $300M (SEC Form D, 2023) | 2026-11-04 | https://theinvestordatabase.com/investors/safar-partners/ |
| Claritas Signal Partners | VC firm | Nashville, TN | Seed, Series A, Series B, Growth | Medtech, Healthtech, AI, Media | New deal, Aug 2026 | $14M (SEC Form D, 2021) | 2026-11-05 | https://theinvestordatabase.com/investors/claritas-signal-partners/ |
| Coyote Ventures | VC firm | San Francisco, CA | Seed | Medtech, Healthtech, Fintech, Impact | Portfolio news, Aug 2026 | $2M (SEC Form D, 2021) | 2026-11-05 | https://theinvestordatabase.com/investors/coyote-ventures/ |
| RPM Ventures | VC firm | Ann Arbor, MI | Seed | Medtech, Space, Future of Work, Healthtech | New fund, Sep 2026 | $165M (SEC Form D, 2026) | 2026-11-04 | https://theinvestordatabase.com/investors/rpm-ventures/ |
| Inspired | VC firm | New York, NY | Seed | Medtech, AI, Fintech, Generalist | New fund, Oct 2026 | $450M (SEC Form D, 2026) | 2026-11-04 | https://theinvestordatabase.com/investors/inspired/ |
| Parkwalk Advisors | SEIS/EIS fund | London, United Kingdom | Seed, Series A, Series B, Growth | Medtech, Healthtech, AI, Industrial Tech | New fund, Sep 2026 | £500M (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/parkwalk/ |
| Reveille | VC firm | New York, NY | Seed | Medtech, Defense Tech, Energy, Space | New fund, Nov 2026 | $40M (SEC Form D, 2025) | 2026-11-04 | https://theinvestordatabase.com/investors/reveille/ |
| NLC Health Ventures | VC firm | Amsterdam, Netherlands | Pre-seed, Seed | Medtech, Healthtech, Biotech | New fund, Sep 2026 | €300M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/nlc-fund-management-b-v/ |
| Angelor | VC firm | Lyon, France | Seed, Series A | Medtech, Healthtech, Biotech, Food and Beverage | New deal, Sep 2026 | €100M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/angelor/ |
| Grand Ventures | VC firm | Grand Rapids, MI | Seed | Medtech, AI, Developer Tools, Fintech | New deal, Sep 2026 | $100M (SEC Form D, 2022) | 2026-11-05 | https://theinvestordatabase.com/investors/grand-ventures/ |
| Blu Ventures | VC firm | Arlington, VA | Seed | Medtech, Healthtech, Cybersecurity, AI | New fund, Jun 2026 | $215M (SEC Form ADV) | 2026-11-05 | https://theinvestordatabase.com/investors/blu-ventures/ |
| Khosla Ventures | VC firm | Menlo Park, CA | Pre-seed, Seed, Series A, Growth | Medtech, AI, Consumer, B2B | New fund, Aug 2026 | $1.9B (SEC Form D, 2025) | 2026-11-04 | https://theinvestordatabase.com/investors/khosla-ventures/ |

You are seeing 25 of 278. The full list adds 253 more investors and 1,351 named decision-makers.

Get all 278 investors and 1,351 named contacts, $49, one-time: https://theinvestordatabase.com/buy/list/seed-medtech-investors
This page: https://theinvestordatabase.com/lists/seed-medtech-investors/

## Method and limits
- Source: 207 of the 278 rows carry an SEC filing (Form D or Form ADV). All 278 have a website we checked. Filing date and fund size are SEC data where a filing exists. Stage, sector and check size are our research.
- Inclusion rule: Organizations that back startups. Individuals, buyout funds and firms we found to be inactive are left out. Sector: the firm states medtech and medical devices as a focus on its own site, or we observed it in the firm's portfolio. Stage: the firm states that it invests at seed.
- Order: Activity score out of 100: recency of the latest fund filing or dated deal (35: full marks within 3 months, then stepping down at 6, 12 and 24 months), share of the observed portfolio in this sector (25; half of that when the sector is stated only), stage focus (15: all of it when seed is the only stage the firm states, split evenly when it states more), size of the fund on file on a log scale (15) and completeness of the public record (10). Stage focus is our research, not an SEC figure. It is a measure of activity and fit, not of quality or returns.
- Fill rates: Of 278 rows: stage 278, sector 278, fund size 215, website 278. In the paid file: named decision-makers on 265 rows, firm email on 119, LinkedIn page on 173, check size on 53.

## Questions
### How many seed medtech investors are there?
We list 278 as of November 2026. 132 of the 278 have a fund filing or a dated deal in the last 12 months.

### Which seed medtech investors raised a new fund in the last 12 months?
71 of the 278 have a fund filing dated in the last 12 months. The most recent on this list are Reveille (Nov 2026), 25Madison Ventures (Oct 2026) and Inspired (Oct 2026).

### What is the typical fund size of seed medtech investors?
The median fund size on file for this list is $50M, across the 148 firms with a size on an SEC Form D. The fund on file is each firm's main fund, which is not always its newest. The other 130 do not disclose a size there.

### How do I contact seed medtech investors?
The paid file holds 1,351 named decision-makers across 265 of these 278 and a firm email for 119. We publish the address a firm lists itself, never a personal email. Each free row links to a profile with the firm's website.

### Where does the data on seed medtech investors come from?
207 of the 278 rows have an SEC filing on file (Form D or Form ADV) and 71 were checked on the firm's own website or an official register. Filing date and fund size come from the filing. Stage, sector and check size are our research. Rows on this list were last checked on 9 Nov 2026 at the latest. The whole file is re-verified twice a year.